Latest News and Press Releases
Want to stay updated on the latest news?
-
Pune, India, March 09, 2023 (GLOBE NEWSWIRE) -- The global thin film drugs market size was valued at USD 7.35 billion in 2020. The market is projected to grow from USD 8.16 billion in 2021 to USD...
-
VANCOUVER, British Columbia, March 09, 2023 (GLOBE NEWSWIRE) -- Rio2 Limited (“Rio2” or “the Company”) (TSXV: RIO; OTCQX: RIOFF; BVL: RIO) is providing an outline of its plans to complete the...
-
TORONTO, March 09, 2023 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. (“MCI”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of...
-
AUSTIN, Texas, March 09, 2023 (GLOBE NEWSWIRE) -- When Vital Farms (Nasdaq: VITL) began as a single-family farm in Austin, TX, we had one mission in mind: bring more ethical food to the table. Over...
-
Increasing awareness within the U.S. capital markets DiagnaMed focused on commercializing CERVAI™, its proprietary Brain Health AI Platform leveraging Generative AI TORONTO, March 09, 2023 (GLOBE...
-
VANCOUVER, British Columbia, March 09, 2023 (GLOBE NEWSWIRE) -- Central Iron Ore Ltd. (CIO – TSX.V) (“CIO” or “the Company”) is pleased to announce results from the February 2023 Diamond drilling...
-
BATON ROUGE, La., March 09, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul...
-
TORONTO, ON, March 09, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today announced that it has received a decision of the Nasdaq Hearings Panel...
-
2022 was the first year with cash receipts from a commercial asset since becoming a royalty aggregator Ebopiprant royalty and milestone license acquisition gives XOMA the potential to earn up to $378...
-
Toronto, March 09, 2023 (GLOBE NEWSWIRE) -- Restaurants Canada proposes a win-win solution for the federal government to save small businesses, and specifically restaurants as they continue to...